Traditional periodontal exams rely on probing, bleeding, pocket depth, and clinical observation. These tools are valuable, but they often identify problems after inflammation has already taken hold.
Dr. Globauer explains that PerioMonitor was created to fill a gap: a simple, affordable,
chairside screening tool that could help detect oral inflammation earlier and make the patient part of the process.
This is not about replacing the clinician. It’s about giving both the clinician and patient a clearer signal.
At the center of PerioMonitor is one key biomarker: neutrophils.
Neutrophils are part of the innate immune system: the body’s rapid-response defense against infection and inflammation. In medicine, white blood cell counts are commonly used to understand immune activity.
Dr. Globauer’s work applies that same logic to the mouth.
Rather than only looking for specific bacteria, PerioMonitor looks at the body’s inflammatory response.
This matters because inflammation is often the real story.
One important distinction from the episode: PerioMonitor is a screening tool, not a diagnostic test.
That difference matters. A screening tool can help flag where closer attention may be needed. It can support triage, guide conversations, and make monitoring more frequent and accessible.
For patients, this can make oral health feel less abstract. Instead of waiting months between appointments to know whether inflammation is improving, clinicians may be able to track changes more regularly.
The episode also explores the limits of microbial testing. Knowing whether certain bacteria are present can be helpful, but microbes do not exist in isolation.
The same bacterial profile may mean different things depending on the person’s immune response, genetics, inflammation level, and microbiome context.
A key idea from the conversation:
The question is not only “What microbes are there?”
It is also “How is the body responding?”
This is where inflammation monitoring becomes especially valuable.
Dr. Globauer also discusses the future of oral probiotics, including research into beneficial strains and compounds that may help regulate the oral microbiome and immune response.
The episode highlights the need for evidence-based oral probiotics designed specifically for the mouth, not simply repurposed from gut health.
The promise is exciting: products that may one day help reduce inflammatory load, support microbial balance, and complement clinical care.
But the message is clear: good oral science takes time, validation, and rigorous testing.
One of the most important themes in the episode is access.
If oral inflammation can be screened in a simple, affordable way, it could help expand preventive care beyond traditional dental settings.
This has implications for underserved communities, public health research, global health, and early intervention.
The future of oral care may not only be more scientific. It may also be more accessible.
PerioMonitor is a chairside screening test designed to help measure periodontal inflammation by looking at neutrophil levels.
Neutrophils are immune cells that act as first responders when the body detects infection or inflammation.
No. In the episode, Dr. Globauer explains that it is designed as a screening tool. It helps identify inflammatory activity that may need closer clinical evaluation.
Inflammation can be an early sign that the oral environment is under stress. Chronic oral inflammation may also connect to broader systemic health concerns.
Not necessarily. The episode emphasizes that oral probiotics should be developed and tested specifically for the mouth’s unique microbiome and immune environment.
The benefits that OSSA brings to your routine
The future of oral health is becoming more preventive, measurable, and connected. By understanding inflammation, immune response, and the oral microbiome, we can move beyond surface-level care and toward smarter daily rituals.
